Breast Surgery with or without Radiotherapy for Ductal Carcinoma in Situ
Author Information
Author(s): Viani Gustavo A, Stefano Eduardo J, Afonso Sérgio L, De Fendi Lígia I, Soares Francisco V, Leon Paola G, Guimarães Flavio S
Primary Institution: Department of Radiation Oncology, Faculty of Medicine of Marília (FAMEMA), Marília, São Paulo, Brazil
Hypothesis
Does radiation therapy following breast-conserving surgery reduce mortality and recurrence rates in women with ductal carcinoma in situ?
Conclusion
Adding radiation therapy to lumpectomy significantly reduces breast cancer recurrence but does not improve survival rates.
Supporting Evidence
- The addition of radiation therapy resulted in a 60% reduction in breast cancer recurrence.
- Patients with high-grade DCIS lesions benefited most from radiation therapy.
- There was no significant difference in overall mortality rates between the two treatment groups.
- Contralateral breast cancer rates were higher in the radiation therapy group.
Takeaway
This study found that women who had radiation after breast surgery had fewer chances of cancer coming back, but it didn't help them live longer.
Methodology
A meta-analysis of randomized controlled trials comparing radiotherapy to observation after breast-conserving surgery.
Potential Biases
Potential publication bias due to the tendency of journals to favor positive studies.
Limitations
The study did not identify specific subgroups of patients who could avoid radiation therapy.
Participant Demographics
Women diagnosed with ductal carcinoma in situ, with no prior history of malignant disease.
Statistical Information
P-Value
<0.00001
Confidence Interval
95% CI 0.33 – 0.60
Statistical Significance
p<0.00001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website